CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-19 | Curley Joanne Chief Development Officer | Option exercise | +700 | $6.37 | $4K | 30,485 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Sale | −700 | $19.76 | $14K | 29,785 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Option exercise | +710 | $2.90 | $2K | 30,495 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Sale | −710 | $18.93 | $13K | 29,785 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Option exercise | +1,451 | $2.90 | $4K | 31,236 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Sale | −1,451 | $19.87 | $29K | 29,785 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Option exercise | +2,766 | $11.00 | $30K | 32,551 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Sale | −2,766 | $18.61 | $51K | 29,785 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Option exercise | +904 | $11.00 | $10K | 30,689 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Sale | −904 | $19.81 | $18K | 29,785 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Option exercise · Stock Option (right to buy) | −1,078 | 12,951 | ||
| 2022-08-19 | Curley Joanne Chief Development Officer | Option exercise · Stock Option (right to buy) | −2,161 | 44,598 | ||
| 2022-08-19 | Curley Joanne Chief Development Officer | Option exercise · Stock Options (right to buy) | −3,670 | 104,547 | ||
| 2022-08-19 | Lin Celia Chief Medical Officer | Grant or award | +12,500 | 12,500 | ||
| 2022-08-19 | Young Joseph R SVP, Finance, Chief Acct Offcr | Grant or award | +15,000 | 16,148 | ||
| 2022-08-19 | Grant Sean Chief Financial Officer | Grant or award | +33,750 | 35,268 | ||
| 2022-08-19 | Fordyce Marshall President and CEO | Grant or award | +43,750 | 181,150 | ||
| 2022-08-17 | Carlyle Group Inc. 10% owner | Option exercise | +9,925 | $11.00 | $109K | 2,970,156 |
| 2022-08-17 | Carlyle Group Inc. 10% owner | Sale | −3,281 | $19.88 | $65K | 2,966,875 |
| 2022-08-17 | Carlyle Group Inc. 10% owner | Sale | −6,472 | $20.42 | $132K | 2,960,403 |
Page 24 of 30 · 581 trades